| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,850 |
2,915 |
$211K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
719 |
619 |
$28K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
610 |
529 |
$27K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
615 |
531 |
$16K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
991 |
773 |
$8K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
91 |
76 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
330 |
244 |
$7K |
| 99215 |
Prolong outpt/office vis |
44 |
42 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
332 |
291 |
$4K |
| 87400 |
|
333 |
248 |
$3K |
| 87430 |
|
256 |
161 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
136 |
69 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
459 |
382 |
$729.15 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
474 |
402 |
$373.66 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
170 |
141 |
$254.90 |
| 36415 |
Collection of venous blood by venipuncture |
152 |
147 |
$196.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
13 |
12 |
$180.62 |
| 93000 |
|
12 |
12 |
$115.88 |
| 81002 |
|
32 |
30 |
$81.26 |
| 82947 |
|
17 |
15 |
$36.00 |
| 1125F |
|
33 |
32 |
$0.00 |
| 1126F |
|
45 |
42 |
$0.00 |
| 3074F |
|
234 |
194 |
$0.00 |
| 3078F |
|
239 |
200 |
$0.00 |